Related Experiment Video
Updated: Aug 16, 2025
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy
Brock D Sherlock1, Adelle C F Coster1
1School of Mathematics and Statistics, University of New South Wales, Sydney, NSW, 2052, Australia.
Abstract:
Oncolytic viruses are a promising new treatment for cancer, whereby viruses are engineered to selectively destroy cancer cells. Mathematical modelling of the dynamics of the virus-tumour system can be modelled to provide insight into the system outcomes under different treatment protocols. In this study key metrics of treatment efficacy were identified and the mathematical model used to develop a decision framework to assess different treatment protocols. The optimal treatment outcome is the interplay between the virus application protocol and the uncertainty about the tumour characteristics. The uncertainty in the model parameters decreases as more data is available for their inference - however to obtain more data more time is required and the tumour then grows in size. Thus, there is an inherent tension whether it is better to wait to know the characteristics of the tumour system better or immediately initiating treatment. It is shown that, for small tumours, parameter inference with limited data does not constrain the choice of treatment protocol and rather only influences longer term decisions.
Insights
Mathematical modeling of oncolytic virus therapy reveals a trade-off between gathering tumor data and initiating treatment. For small tumors, early treatment is often optimal, as data collection delays tumor growth.
Area of Science:
- Oncolytic virotherapy
- Mathematical oncology
- Cancer systems biology
Background:
- Oncolytic viruses offer a novel approach to cancer treatment by selectively targeting and destroying malignant cells.
- Mathematical modeling is crucial for understanding virus-tumor dynamics and optimizing treatment strategies.
Purpose of the Study:
- To identify key metrics for oncolytic virus treatment efficacy.
- To develop a mathematical decision framework for assessing various treatment protocols.
- To analyze the tension between data acquisition for parameter inference and timely treatment initiation.
Main Methods:
- Development of a mathematical model for virus-tumor system dynamics.
- Identification of key treatment efficacy metrics.
- Construction of a decision framework to evaluate different treatment protocols under parameter uncertainty.
Main Results:
- The optimal treatment outcome depends on the interplay between virus application strategy and tumor characteristic uncertainty.
- Acquiring more data to reduce parameter uncertainty leads to increased tumor size due to time delays.
- For small tumors, limited data does not significantly constrain initial treatment choices, primarily impacting long-term decisions.
Conclusions:
- A balance must be struck between refining tumor model parameters and initiating oncolytic virus treatment promptly.
- The decision to delay treatment for better characterization is often suboptimal for smaller tumors.
- Mathematical modeling provides a framework for personalized oncolytic virotherapy by navigating treatment uncertainties.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy